Text Size
394 studies found for:    "Neuroblastoma"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
Condition: Neuroblastoma
Intervention: Biological: autologous neuroblastoma vaccine
22 Unknown † Biomarkers in Samples From Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Genetic: western blotting;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
23 Unknown † Biomarkers in Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: DNA analysis;   Genetic: DNA methylation analysis;   Genetic: RNA analysis;   Genetic: comparative genomic hybridization;   Genetic: mutation analysis;   Genetic: polymorphism analysis
24 Active, not recruiting Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: RNA analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Genetic: western blotting;   Other: enzyme-linked immunosorbent assay;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry
25 Active, not recruiting Studying Gene Expression in Samples From Younger Patients With Neuroblastoma
Conditions: Neoplastic Syndrome;   Neuroblastoma
Interventions: Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: enzyme-linked immunosorbent assay;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: medical chart review
26 Active, not recruiting Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis;   Other: medical chart review
27 Completed Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: monoclonal antibody 3F8;   Biological: sargramostim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: isotretinoin;   Drug: thiotepa;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: drug resistance inhibition treatment;   Procedure: peripheral blood stem cell transplantation;   Procedure: syngeneic bone marrow transplantation;   Radiation: radiation therapy
28 Unknown † Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery
29 Active, not recruiting Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: RNA analysis;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis
30 Unknown † Study of DNA in Blood Samples From Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis
31 Completed Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: monoclonal antibody 3F8;   Drug: etoposide;   Drug: isotretinoin
32 Active, not recruiting Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: topotecan hydrochloride
33 Unknown † Study of Specimens From Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis
34 Unknown † Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
35 Active, not recruiting Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: anti-GD2 murine IgG3 monoclonal antibody 3F8
36 Completed Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
37 Unknown † Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: ifosfamide;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: iobenguane I 131;   Radiation: radiation therapy
38 Completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: etoposide phosphate;   Drug: ifosfamide;   Drug: isotretinoin;   Drug: melphalan;   Drug: thiotepa;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
39 Unknown † Surgery in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Intervention: Procedure: surgical procedure
40 Completed Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: monoclonal antibody 3F8;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mesna;   Drug: perfosfamide;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: in vitro-treated bone marrow transplantation;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET photon therapy;   Radiation: radioisotope therapy
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years